Early access
Sign in
Not yet taking people in United StatesNo phase

Online single session to help parents of anxious children with neurodevelopmental conditions

Tests a brief online program teaching parents to respond to anxious avoidance.

Key facts

Who runs it
Boston University Charles River Campus
Where
Boston, United StatesSee the site
Trial code
Registry title
Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance
Status
Not yet recruiting
People taking part
50 people, planned
Started
Nov 2026
Expected to end
Dec 2027
Type of study
Interventional
Treatments tested
  • EMPOWER-ND
Record updated
27 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adult parents or caregivers of a child aged 5-14 with a neurodevelopmental disorder such as autism or ADHD. It tests a brief online program on anxiety-related behaviors.

Age
Parent or caregiver aged 18 years or older; the child must be 5-14 years old.
Sex
Any sex can join.
Disease stage
The child has a clinical diagnosis of a neurodevelopmental disorder, such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), or a related condition.

Main reasons for not taking part

  • Not living in the United States
  • Cannot read and understand English
  • No reliable internet or a device that can do videoconferencing

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Adult parent or primary caregiver of a child between the ages of 5-14 years
  • The child has a clinical diagnosis of a neurodevelopmental disorder, such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), or a related neurodevelopmental condition
  • Resides in the United States
  • Able to read and understand English, as the survey and study materials are provided in English
  • Has reliable internet connectivity and access to a device that can accommodate videoconferencing

Who cannot take part

  • If any of the inclusion criteria are not met

Where in United States

  • Boston University (Charles River Campus)Boston, United StatesContact: Jenna Sung, PhDNot yet recruiting

About the trial

What the trial wants to find out

This study will inform the development of a brief online program to help parents better understand and respond to anxiety-related behaviors in children with neurodevelopmental disorders (NDDs) such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), intellectual disability, and learning disorders). Many neurodiverse children experience high levels of anxiety, which can appear as avoidance, emotional distress, or challenging behaviors that are difficult for parents to interpret and manage.

Read full original descriptionShow less

The purpose of this research is to evaluate EMPOWER-ND with its digital, single-session intervention (SSI) that provides practical parenting strategies for addressing anxiety-related behaviors in neurodiverse children. Parents of eligible children aged 5-14 with neurodevelopmental conditions will be invited to enroll in the research study.

The group in the trial

  • EMPOWER-NDTreatment being tested

    Participants will receive the EMPOWER-ND intervention to assist children struggling with anxious avoidance

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Project EMPOWER-Neuro Developmental Disabilities (ND): Single Session Support for Parents of Children Struggling With Anxious Avoidance
Plain-language title
Online single session to help parents of anxious children with neurodevelopmental conditionsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
27 October 2026